Oncotelic Therapeutics, Inc. Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31)
Oncotelic Therapeutics, Inc. (OTLC) reported Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) of $1.23 million for the 12-month period ending 2011-12-31, per its 10-K filed 2013-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostCostIncurredToDate · last filed 2013-03-15
- Oncotelic Therapeutics, Inc. restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for fiscal 2011 was $1.23M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 12 month |
|---|---|
| 2011-12-31 | $1.23M 10-K · filed 2013-03-15 |